H.B. Fuller Company (FUL)
NYSE:FUL
Want to see FUL full AI Analyst Report?
Earnings Data
Report Date
Sep 30, 2026After Close (Confirmed)
Period Ending
2026 (Q3)Consensus EPS Forecast
1.47Last Year’s EPS
1.26Same Quarter Last Year
Strong Buy
Based on 6 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
Overall the call was constructive: the company delivered solid Q2 results with revenue, EBITDA, margin and EPS expansion, record second‑quarter cash flow, and clear operational execution amid supply disruptions. Management provided improved full‑year guidance and outlined a strategic, scale‑enhancing acquisition (AMS) with sizable identified synergies that should accelerate medical exposure and margin expansion. Offsetting these positives are continued raw material inflation and supply‑chain disruption, near‑term volume weakness (mid‑single digit expected in H2), and a meaningful near‑term increase in leverage (pro forma ~4x) that prompted investor pushback and share price weakness. Management expects to deleverage within two years and to realize synergies over 2028–2030, but these bring execution and timing risk.Company Guidance
Consolidated Revenue Growth
Total revenue increased 5.8% year‑over‑year in Q2 FY2026, with organic revenue up 2.6% after adjusting for currency and acquisitions; pricing contributed ~3% while volume was slightly negative.
Profitability Improvement — EBITDA and EPS
Adjusted EBITDA was $181 million, up 9% year‑over‑year, with EBITDA margin expanding to 19.1% (up 70 basis points). Adjusted EPS was $1.41, up 19% versus Q2 2025.
Gross Margin Expansion and SG&A Discipline
Adjusted gross profit margin increased to 34.2% (up 200 basis points year‑over‑year). Adjusted SG&A rose 11% YoY but was ~3% higher excluding FX and higher variable compensation tied to better projected income.
Record Quarterly Operating Cash Flow and Working Capital Improvement
Cash flow from operations improved to $121 million (record for a second quarter). Net working capital was 16.4% of annualized net revenue, improving by 260 basis points sequentially.
Segment Outperformance — BAS and HHC
Building & Advanced Solutions (BAS) organic sales grew 6% YoY with EBITDA up 10%. Healthcare & Consumer (HHC) organic revenue rose 3% and HHC EBITDA margin expanded 230 basis points to 17.9%, driven by pricing and reliable supply performance.
Engineering Adhesives Strength (Excluding Solar)
Engineering Adhesives (EA) organic revenue increased ~5% in Q2 excluding the exited lower‑margin solar business; aerospace grew >30% organically, and electronics and general industries delivered double‑digit growth.
Updated Full‑Year Financial Guidance
Company raised midpoint of full‑year targets: net revenue still expected mid‑single‑digit growth; organic revenue low‑single digits; adjusted EBITDA increased to $650M–$675M; adjusted EPS raised to $4.60–$4.90; full‑year CFO guidance increased to $300M–$325M.
Strategic Acquisition — Advanced Medical Solutions (AMS)
Announced all‑cash offer for AMS at GBP 2.85/share (EV ~GBP 715M). AMS FY2025: ~$302M revenue and ~$54M adjusted EBITDA (18% margin). Identified ~$55M run‑rate synergies (≈$20M commercial, $35M cost) and expects the deal to materially upscale medical business and accelerate margin expansion.
FUL Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
FUL Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Jun 24, 2026 | $64.60 | $61.95 | -4.10% |
Mar 25, 2026 | $56.48 | $56.76 | +0.49% |
Jan 14, 2026 | $64.23 | $63.01 | -1.90% |
Jun 25, 2025 | $55.09 | $61.02 | +10.78% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does H.B. Fuller Company (FUL) report earnings?
H.B. Fuller Company (FUL) is schdueled to report earning on Sep 30, 2026, After Close (Confirmed).
What is H.B. Fuller Company (FUL) earnings time?
H.B. Fuller Company (FUL) earnings time is at Sep 30, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is FUL EPS forecast?
FUL EPS forecast for the fiscal quarter 2026 (Q3) is 1.47.
